Sculptor Capital’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-48,700
Closed -$6.1M 738
2014
Q4
$6.1M Hold
48,700
0.02% 431
2014
Q3
$5.93M Hold
48,700
0.02% 491
2014
Q2
$5.75M Sell
48,700
-131,400
-73% -$15.5M 0.02% 493
2014
Q1
$21.7M Buy
180,100
+700
+0.4% +$83.2K 0.07% 254
2013
Q4
$20M Sell
179,400
-197,900
-52% -$19.7M 0.05% 341
2013
Q3
$34.8M Buy
377,300
+63,000
+20% +$5.7M 0.1% 262
2013
Q2
$26.6M Buy
+314,300
New +$26.2M 0.08% 281

Other funds holding TMO

Sculptor Capital's TMO Position: Q2 2023 in Review

Sculptor Capital sold out of Thermo Fisher Scientific (TMO) in Q2 2023, closing a stake of 211,071 shares — an estimated $122M sold.

Sculptor Capital first reported a position in TMO in Q2 2013 and held it in 15 quarters. The position peaked at $610M in Q4 2013. 2,387 funds tracked by Wall St. Rank hold TMO as of Q2 2023.

  • Sculptor Capital reported no remaining Thermo Fisher Scientific position as of Q2 2023 after selling out during the quarter.
  • Sculptor Capital sold 211,071 Thermo Fisher Scientific shares in Q2 2023, an estimated $122M.
  • Sculptor Capital first reported a position in Thermo Fisher Scientific in Q2 2013 and held it in 15 quarters.
  • Sculptor Capital's Thermo Fisher Scientific position peaked at $610M in Q4 2013.
  • 2,387 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2023.

Based on Sculptor Capital's 13F filing for Q2 2023, filed 14 Aug 2023.